Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1987 Oct 15;137(8):722–726.

Comparison of one- and two-dose regimens of influenza vaccine for elderly men.

M Levine 1, B L Beattie 1, D M McLean 1
PMCID: PMC1267308  PMID: 3651943

Abstract

In November and December 1984, 102 male residents of a long-term care facility (mean age 74.6 [extremes 59 and 97] years) received 0.5 ml of trivalent inactivated whole-virion influenza vaccine, containing 15 micrograms of the hemagglutinin of each of A/Philippines/2/82 (H3N2), A/Chile/83 (H1N1) and B/USSR/83. A second dose of the vaccine was administered to a subgroup of 55 randomly chosen subjects 8 weeks later. Serum samples were collected from all the subjects before and 4, 8, 12 and 16 weeks after administration of the first dose and were assayed for hemagglutinin-inhibiting (HAI) antibody to each of the three antigens. At 8 weeks there were significant increases (p less than 0.05) in the geometric mean titre of antibody and in the proportion of subjects with HAI antibody titres of 1:40 or more (except to the B/USSR antigen) in both groups. There were no differences between the groups at 8 weeks or at 16 weeks (8 weeks after administration of the second dose of vaccine) in the frequency of seroconversion, the geometric mean titre or the proportion of subjects with HAI antibody titres of 1:40 or more. Overall, 60%, 32% and 13% of the 102 subjects had titres of 1:40 or more to the A/Philippines, A/Chile and B/USSR antigens respectively at 16 weeks. The results suggest that a second dose of influenza vaccine given 8 weeks after the first does not enhance the immune response in elderly men and that a substantial proportion of this population remains unprotected against infection (having HAI antibody titres of less than 1:40) during the influenza season.

Full text

PDF
722

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Douglas R. G., Jr, Bentley D. W., Brandriss M. W. Responses of elderly and chronically ill subjects to bivalent influenza A/New Jersey/8/76 (Hsw1N1)-A/Victoria/3/75 (H3N2) vaccines. J Infect Dis. 1977 Dec;136 (Suppl):S526–S532. doi: 10.1093/infdis/136.supplement_3.s526. [DOI] [PubMed] [Google Scholar]
  2. Dowdle W. R., Coleman M. T., Mostow S. R., Kaye H. S., Schoenbaum S. C. Inactivated influenza vaccines. 2. Laboratory indices of protection. Postgrad Med J. 1973 Mar;49(569):159–163. doi: 10.1136/pgmj.49.569.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ershler W. B., Moore A. L., Socinski M. A. Influenza and aging: age-related changes and the effects of thymosin on the antibody response to influenza vaccine. J Clin Immunol. 1984 Nov;4(6):445–454. doi: 10.1007/BF00916574. [DOI] [PubMed] [Google Scholar]
  4. Hobson D., Baker F. A., Curry R. L. Effect of influenza vaccines in stimulating antibody in volunteers with prior immunity. Lancet. 1973 Jul 21;2(7821):155–156. doi: 10.1016/s0140-6736(73)93106-1. [DOI] [PubMed] [Google Scholar]
  5. La Montagne J. R., Noble G. R., Quinnan G. V., Curlin G. T., Blackwelder W. C., Smith J. I., Ennis F. A., Bozeman F. M. Summary of clinical trials of inactivated influenza vaccine - 1978. Rev Infect Dis. 1983 Jul-Aug;5(4):723–736. doi: 10.1093/clinids/5.4.723. [DOI] [PubMed] [Google Scholar]
  6. Levine M., Beattie B. L., McLean D. M., Corman D. Characterization of the immune response to trivalent influenza vaccine in elderly men. J Am Geriatr Soc. 1987 Jul;35(7):609–615. doi: 10.1111/j.1532-5415.1987.tb04335.x. [DOI] [PubMed] [Google Scholar]
  7. MacKenzie J. S. Influenza subunit vaccine: antibody responses to one and two doses of vaccine and length of response, with particular reference to the elderly. Br Med J. 1977 Jan 22;1(6055):200–202. doi: 10.1136/bmj.1.6055.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mitchell D. M., McMichael A. J., Lamb J. R. The immunology of influenza. Br Med Bull. 1985 Jan;41(1):80–85. doi: 10.1093/oxfordjournals.bmb.a072031. [DOI] [PubMed] [Google Scholar]
  9. Potter C. W., Oxford J. S. Determinants of immunity to influenza infection in man. Br Med Bull. 1979 Jan;35(1):69–75. doi: 10.1093/oxfordjournals.bmb.a071545. [DOI] [PubMed] [Google Scholar]
  10. Quinnan G. V., Schooley R., Dolin R., Ennis F. A., Gross P., Gwaltney J. M. Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis. 1983 Jul-Aug;5(4):748–757. doi: 10.1093/clinids/5.4.748. [DOI] [PubMed] [Google Scholar]
  11. Ruben F. L. Prevention of influenza in the elderly. J Am Geriatr Soc. 1982 Sep;30(9):577–580. doi: 10.1111/j.1532-5415.1982.tb05666.x. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES